美华国际美股招股说明书(2025-07-24版)

Warrants to Purchase 1,205,255 Ordinary Shares This prospectus supplement amends and supplements the prospectus dated February 27, 2024, as supplemented or amended from timeto time (the “Prospectus”), which forms a part of our Registration Statement on Form F-1 (Registration Statement No. 333-276882).This prospectus supplement is being filed to update and supplement the information included or incorporated by reference in theProspectus with the information contained in our Annual Report on Form 20-F, which was filed with the Securities and ExchangeCommission on April 25, 2025 (the “Annual Report”). Accordingly, we have attached the Annual Report to this prospectussupplement. This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not bedelivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectussupplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in theProspectus and this prospectus supplement, you should rely on the information in this prospectus supplement. Our ordinary shares are listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “MHUA.” On July 23, 2025, the lastreported sale price of our ordinary shares on Nasdaq was $0.405. We are a “foreign private issuer” as defined in the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”),and are exempt from certain rules under the Exchange Act that impose certain disclosure obligations and proceduralrequirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers, directors and principalshareholders are exempt from the reporting and “short-swing” profit recovery provisions under Section 16 of the ExchangeAct. Moreover, we are not required to file periodic reports and financial statements with the U.S. Securities and ExchangeCommission as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.Additionally, Nasdaq rules allow foreign private issuers to follow home country practices in lieu of certain of Nasdaq’scorporate governance rules. As a result, our shareholders may not have the same protections afforded to shareholders ofcompanies that are subject to all Nasdaq corporate governance requirements. Investing in our securities involves a high degree of risk. Before making an investment decision, please read the informationunder the heading “Risk Factors” beginning on page 19 of the Prospectus and the risk factors set forth in the Annual Report. None of the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesecurities offered by this prospectus supplement or the Prospectus or determined if the Prospectus or this prospectussupplement is truthful or complete. Any representation to the contrary is a criminal offense. The date of this prospectus supplement is July 24, 2025. UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 FORM 20-F (Mark One)☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACTOF 1934 OR For the fiscal year ended December 31, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ OR ☐SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 Date of event requiring this shell company report: Commission file number:001-41291 MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO., LTD.(Exact name of Registrant as specified in its charter) Not Applicable(Translation of Registrant’s name into English) Cayman Islands(Jurisdiction of incorporation or organization) 88 Tongda Road, Touqiao TownGuangling District, Yangzhou, 225000People’s Republic of China(Address of principal executive offices) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on whichregisteredOrdinary Share, $0.0005 par valueMHUANasdaq Global Market Securities registered or to be registered pursuant to Section 12(g) of the Act. None(Title of Class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. None(Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the periodcovered by the annual report (December 31, 2024): 31,904,468 shares of common stock Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☐No☒ If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section13 or 15(d) of the Securities Exchange Act of 1934. Yes☐No☒ Indicate by check mark whether the registra